A detailed history of Four Thought Financial, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Four Thought Financial, LLC holds 2,156 shares of STRO stock, worth $6,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,156
Previous 2,156 -0.0%
Holding current value
$6,230
Previous $11,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$3.41 - $8.95 $1,353 - $3,553
397 Added 22.57%
2,156 $11,000
Q3 2021

Nov 12, 2021

BUY
$16.88 - $22.38 $422 - $559
25 Added 1.44%
1,759 $33,000
Q2 2021

Nov 12, 2021

SELL
$18.03 - $23.82 $1,550 - $2,048
-86 Reduced 4.73%
1,734 $32,000
Q1 2021

Nov 12, 2021

BUY
$20.29 - $27.54 $14,669 - $19,911
723 Added 65.91%
1,820 $41,000
Q4 2020

Nov 12, 2021

BUY
$10.16 - $23.98 $11,145 - $26,306
1,097 New
1,097 $23,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $151M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.